Avalon GloboCare Corp.
(NASDAQ : AVCO)

( )
AVCO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -16.36%57.710.0%$1537.44m
GILDGilead Sciences, Inc. -0.22%73.181.0%$1287.43m
AMGNAmgen, Inc. -1.78%222.401.3%$637.47m
REGNRegeneron Pharmaceuticals, Inc. -4.33%545.212.5%$616.99m
NVAXNovavax, Inc. 4.47%48.17102.0%$608.66m
VRTXVertex Pharmaceuticals, Inc. -6.48%266.501.9%$516.32m
BIIBBiogen, Inc. -2.84%295.871.6%$413.02m
ILMNIllumina, Inc. -0.08%354.413.5%$354.75m
SRNESorrento Therapeutics, Inc. 3.95%5.271.8%$307.06m
SGENSeattle Genetics, Inc. -2.59%151.736.1%$243.04m
ALXNAlexion Pharmaceuticals, Inc. 1.28%102.802.0%$224.06m
AAgilent Technologies, Inc. 1.37%86.141.6%$196.15m
CODXCo-Diagnostics, Inc. -2.80%18.030.0%$185.93m
MGNXMacroGenics, Inc. -6.82%23.646.2%$178.27m
BMRNBioMarin Pharmaceutical, Inc. 6.39%103.744.3%$172.63m

Company Profile

Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and provision of healthcare services. It operates through the following segments: Real Property Operating; Medical Related Consulting Services; and Development Services and Sales of Developed Products. It offers regenerative medicine, cell-based immunotherapy, exosome technology, and rehabilitation medicine through Avalon Cell and Avalon Rehab platforms. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.